InvestorsHub Logo
Followers 52
Posts 3352
Boards Moderated 0
Alias Born 10/26/2013

Re: antihama post# 1602

Wednesday, 03/29/2017 12:14:24 PM

Wednesday, March 29, 2017 12:14:24 PM

Post# of 3283
Wow. The P2 Poziotinib in EGFR Exon 20 Mutant Advanced Non-Small Cell Lung Cancer (NSCLC) started recruiting patients as of March 17th. A month ago they estimated study start date as April. So that was pretty quick. They're not kidding this time. We really could see results this year.

PS Just realized the study started on St. Patty's Day. Maybe it will have the luck of the Irish to move it along :)